HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 06-MAR-14 4P38 TITLE HUMAN 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 IN COMPLEX WITH TITLE 2 AZD8329 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,11-BETA-HSD1; COMPND 5 EC: 1.1.1.146; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSD11B1, HSD11, HSD11L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALPHA BETA, ROSSMANN FOLD, NADP, OXIDOREDUCTASE-OXIDOREDUCTASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.OGG,D.HARGREAVES,S.GERHARDT REVDAT 4 28-FEB-24 4P38 1 REMARK REVDAT 3 01-NOV-17 4P38 1 SOURCE JRNL REMARK REVDAT 2 12-NOV-14 4P38 1 KEYWDS REVDAT 1 30-APR-14 4P38 0 JRNL AUTH J.S.SCOTT,J.DESCHOOLMEESTER,E.KILGOUR,R.M.MAYERS,M.J.PACKER, JRNL AUTH 2 D.HARGREAVES,S.GERHARDT,D.J.OGG,A.REES,N.SELMI,A.STOCKER, JRNL AUTH 3 J.G.SWALES,P.R.WHITTAMORE JRNL TITL NOVEL ACIDIC 11 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (11 JRNL TITL 2 BETA-HSD1) INHIBITOR WITH REDUCED ACYL GLUCURONIDE JRNL TITL 3 LIABILITY: THE DISCOVERY OF JRNL TITL 4 4-[4-(2-ADAMANTYLCARBAMOYL) JRNL TITL 5 -5-TERT-BUTYL-PYRAZOL-1-YL]BENZOIC ACID (AZD8329). JRNL REF J.MED.CHEM. V. 55 10136 2012 JRNL REFN ISSN 1520-4804 JRNL PMID 23088558 JRNL DOI 10.1021/JM301252N REMARK 0 REMARK 0 THIS IS A PDBCHK OUTPUT, CREATED THU OCT 18 11:43:16 2012 ON REMARK 0 HOST: UKAPDWLX049. ORIGINAL FILE: /XTAL/WORK/BHSD/AZ12782812/ REMARK 0 DEPOSIT/BHSD-AZ12782812_FI REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 20763 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1062 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.95 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.68 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2986 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2794 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2840 REMARK 3 BIN R VALUE (WORKING SET) : 0.2776 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.89 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4068 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 160 REMARK 3 SOLVENT ATOMS : 29 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 103.6 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.92910 REMARK 3 B22 (A**2) : -8.92910 REMARK 3 B33 (A**2) : 17.85810 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.505 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.668 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.340 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.682 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.346 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4323 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5873 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1501 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 81 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 666 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4323 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 568 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5144 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.27 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.01 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -13.0786 65.2825 30.4737 REMARK 3 T TENSOR REMARK 3 T11: -0.1326 T22: -0.1709 REMARK 3 T33: -0.1187 T12: -0.0446 REMARK 3 T13: 0.0091 T23: 0.0303 REMARK 3 L TENSOR REMARK 3 L11: 1.4228 L22: 1.7259 REMARK 3 L33: 3.1992 L12: 0.0283 REMARK 3 L13: 0.1467 L23: -0.6526 REMARK 3 S TENSOR REMARK 3 S11: 0.0176 S12: 0.0307 S13: 0.2523 REMARK 3 S21: 0.0503 S22: 0.0086 S23: -0.0052 REMARK 3 S31: -0.5638 S32: -0.1337 S33: -0.0262 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -4.3013 38.1247 38.8979 REMARK 3 T TENSOR REMARK 3 T11: -0.1175 T22: -0.1336 REMARK 3 T33: -0.1738 T12: -0.0358 REMARK 3 T13: -0.0835 T23: 0.0031 REMARK 3 L TENSOR REMARK 3 L11: 1.2478 L22: 2.0845 REMARK 3 L33: 3.0682 L12: -0.2791 REMARK 3 L13: 0.7561 L23: -0.4082 REMARK 3 S TENSOR REMARK 3 S11: 0.1063 S12: -0.0373 S13: -0.2163 REMARK 3 S21: -0.0940 S22: 0.0245 S23: -0.0233 REMARK 3 S31: 0.7063 S32: 0.2255 S33: -0.1308 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4P38 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000200614. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.514 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.9L REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20969 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.11100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.54000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 42% PEG400, 100 MM TRIS-HCL PH 8.5 AND REMARK 280 2 MM COMPOUND, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.92667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 89.85333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 89.85333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 44.92667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: GEL FILTRATION CONFIRMS THE DIMERIZATION OF THE PROTEIN IN REMARK 300 SOLUTION REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -91.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 19400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -202.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 44.92667 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 229 REMARK 465 ILE B 290 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 288 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 290 CG1 CG2 CD1 REMARK 470 ILE B 230 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 65 177.86 178.27 REMARK 500 ASN A 119 -31.30 -130.30 REMARK 500 HIS A 130 -67.59 -126.79 REMARK 500 PHE A 144 -65.06 -122.49 REMARK 500 SER A 169 -158.43 -109.47 REMARK 500 LYS A 174 -34.19 -131.44 REMARK 500 LEU A 179 -1.74 74.84 REMARK 500 ARG A 288 32.25 -84.06 REMARK 500 PHE A 289 -34.45 -133.02 REMARK 500 ALA B 65 179.40 178.35 REMARK 500 ASN B 119 -32.72 -130.74 REMARK 500 HIS B 130 -66.99 -126.55 REMARK 500 PHE B 144 -66.13 -122.39 REMARK 500 SER B 169 -158.03 -108.64 REMARK 500 LYS B 174 -33.25 -130.74 REMARK 500 LEU B 179 -1.66 72.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NDP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 21T A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NDP B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 21T B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HFR RELATED DB: PDB REMARK 900 4HFR CONTAINS THE SAME PROTEIN COMPLEXED TO ANOTHER LIGAND DBREF 4P38 A 26 290 UNP P28845 DHI1_HUMAN 26 290 DBREF 4P38 B 26 290 UNP P28845 DHI1_HUMAN 26 290 SEQADV 4P38 LEU A 179 UNP P28845 MET 179 CONFLICT SEQADV 4P38 ARG A 262 UNP P28845 LEU 262 CONFLICT SEQADV 4P38 SER A 272 UNP P28845 CYS 272 CONFLICT SEQADV 4P38 GLU A 278 UNP P28845 PHE 278 CONFLICT SEQADV 4P38 TRP A 286 UNP P28845 MET 286 CONFLICT SEQADV 4P38 LEU B 179 UNP P28845 MET 179 CONFLICT SEQADV 4P38 ARG B 262 UNP P28845 LEU 262 CONFLICT SEQADV 4P38 SER B 272 UNP P28845 CYS 272 CONFLICT SEQADV 4P38 GLU B 278 UNP P28845 PHE 278 CONFLICT SEQADV 4P38 TRP B 286 UNP P28845 MET 286 CONFLICT SEQRES 1 A 265 GLU PHE ARG PRO GLU MET LEU GLN GLY LYS LYS VAL ILE SEQRES 2 A 265 VAL THR GLY ALA SER LYS GLY ILE GLY ARG GLU MET ALA SEQRES 3 A 265 TYR HIS LEU ALA LYS MET GLY ALA HIS VAL VAL VAL THR SEQRES 4 A 265 ALA ARG SER LYS GLU THR LEU GLN LYS VAL VAL SER HIS SEQRES 5 A 265 CYS LEU GLU LEU GLY ALA ALA SER ALA HIS TYR ILE ALA SEQRES 6 A 265 GLY THR MET GLU ASP MET THR PHE ALA GLU GLN PHE VAL SEQRES 7 A 265 ALA GLN ALA GLY LYS LEU MET GLY GLY LEU ASP MET LEU SEQRES 8 A 265 ILE LEU ASN HIS ILE THR ASN THR SER LEU ASN LEU PHE SEQRES 9 A 265 HIS ASP ASP ILE HIS HIS VAL ARG LYS SER MET GLU VAL SEQRES 10 A 265 ASN PHE LEU SER TYR VAL VAL LEU THR VAL ALA ALA LEU SEQRES 11 A 265 PRO MET LEU LYS GLN SER ASN GLY SER ILE VAL VAL VAL SEQRES 12 A 265 SER SER LEU ALA GLY LYS VAL ALA TYR PRO LEU VAL ALA SEQRES 13 A 265 ALA TYR SER ALA SER LYS PHE ALA LEU ASP GLY PHE PHE SEQRES 14 A 265 SER SER ILE ARG LYS GLU TYR SER VAL SER ARG VAL ASN SEQRES 15 A 265 VAL SER ILE THR LEU CYS VAL LEU GLY LEU ILE ASP THR SEQRES 16 A 265 GLU THR ALA MET LYS ALA VAL SER GLY ILE VAL HIS MET SEQRES 17 A 265 GLN ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU ILE ILE SEQRES 18 A 265 LYS GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR TYR ASP SEQRES 19 A 265 SER SER ARG TRP THR THR LEU LEU ILE ARG ASN PRO SER SEQRES 20 A 265 ARG LYS ILE LEU GLU GLU LEU TYR SER THR SER TYR ASN SEQRES 21 A 265 TRP ASP ARG PHE ILE SEQRES 1 B 265 GLU PHE ARG PRO GLU MET LEU GLN GLY LYS LYS VAL ILE SEQRES 2 B 265 VAL THR GLY ALA SER LYS GLY ILE GLY ARG GLU MET ALA SEQRES 3 B 265 TYR HIS LEU ALA LYS MET GLY ALA HIS VAL VAL VAL THR SEQRES 4 B 265 ALA ARG SER LYS GLU THR LEU GLN LYS VAL VAL SER HIS SEQRES 5 B 265 CYS LEU GLU LEU GLY ALA ALA SER ALA HIS TYR ILE ALA SEQRES 6 B 265 GLY THR MET GLU ASP MET THR PHE ALA GLU GLN PHE VAL SEQRES 7 B 265 ALA GLN ALA GLY LYS LEU MET GLY GLY LEU ASP MET LEU SEQRES 8 B 265 ILE LEU ASN HIS ILE THR ASN THR SER LEU ASN LEU PHE SEQRES 9 B 265 HIS ASP ASP ILE HIS HIS VAL ARG LYS SER MET GLU VAL SEQRES 10 B 265 ASN PHE LEU SER TYR VAL VAL LEU THR VAL ALA ALA LEU SEQRES 11 B 265 PRO MET LEU LYS GLN SER ASN GLY SER ILE VAL VAL VAL SEQRES 12 B 265 SER SER LEU ALA GLY LYS VAL ALA TYR PRO LEU VAL ALA SEQRES 13 B 265 ALA TYR SER ALA SER LYS PHE ALA LEU ASP GLY PHE PHE SEQRES 14 B 265 SER SER ILE ARG LYS GLU TYR SER VAL SER ARG VAL ASN SEQRES 15 B 265 VAL SER ILE THR LEU CYS VAL LEU GLY LEU ILE ASP THR SEQRES 16 B 265 GLU THR ALA MET LYS ALA VAL SER GLY ILE VAL HIS MET SEQRES 17 B 265 GLN ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU ILE ILE SEQRES 18 B 265 LYS GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR TYR ASP SEQRES 19 B 265 SER SER ARG TRP THR THR LEU LEU ILE ARG ASN PRO SER SEQRES 20 B 265 ARG LYS ILE LEU GLU GLU LEU TYR SER THR SER TYR ASN SEQRES 21 B 265 TRP ASP ARG PHE ILE HET NDP A 301 48 HET 21T A 302 31 HET CL A 303 1 HET NDP B 301 48 HET 21T B 302 31 HET CL B 303 1 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM 21T 4-[4-(2-ADAMANTYLCARBAMOYL)-5-TERT-BUTYL-PYRAZOL-1- HETNAM 2 21T YL]BENZOIC ACID HETNAM CL CHLORIDE ION FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 21T 2(C25 H31 N3 O3) FORMUL 5 CL 2(CL 1-) FORMUL 9 HOH *29(H2 O) HELIX 1 AA1 ARG A 28 GLN A 33 5 6 HELIX 2 AA2 LYS A 44 MET A 57 1 14 HELIX 3 AA3 SER A 67 GLY A 82 1 16 HELIX 4 AA4 ASP A 95 GLY A 111 1 17 HELIX 5 AA5 ASP A 132 PHE A 144 1 13 HELIX 6 AA6 PHE A 144 SER A 161 1 18 HELIX 7 AA7 ALA A 172 LYS A 174 5 3 HELIX 8 AA8 VAL A 180 SER A 204 1 25 HELIX 9 AA9 THR A 220 SER A 228 1 9 HELIX 10 AB1 PRO A 237 LEU A 251 1 15 HELIX 11 AB2 SER A 261 ARG A 269 1 9 HELIX 12 AB3 ASN A 270 TYR A 284 1 15 HELIX 13 AB4 ARG B 28 GLN B 33 5 6 HELIX 14 AB5 LYS B 44 MET B 57 1 14 HELIX 15 AB6 SER B 67 GLY B 82 1 16 HELIX 16 AB7 ASP B 95 GLY B 111 1 17 HELIX 17 AB8 ASP B 132 PHE B 144 1 13 HELIX 18 AB9 PHE B 144 GLN B 160 1 17 HELIX 19 AC1 ALA B 172 LYS B 174 5 3 HELIX 20 AC2 VAL B 180 SER B 204 1 25 HELIX 21 AC3 THR B 220 SER B 228 1 9 HELIX 22 AC4 PRO B 237 LEU B 251 1 15 HELIX 23 AC5 SER B 261 ARG B 269 1 9 HELIX 24 AC6 ASN B 270 TYR B 284 1 15 SHEET 1 AA1 7 SER A 85 TYR A 88 0 SHEET 2 AA1 7 HIS A 60 VAL A 63 1 N VAL A 61 O SER A 85 SHEET 3 AA1 7 LYS A 36 VAL A 39 1 N VAL A 37 O HIS A 60 SHEET 4 AA1 7 MET A 115 LEU A 118 1 O ILE A 117 N ILE A 38 SHEET 5 AA1 7 SER A 164 SER A 170 1 O VAL A 166 N LEU A 116 SHEET 6 AA1 7 SER A 209 LEU A 215 1 O THR A 211 N VAL A 167 SHEET 7 AA1 7 GLU A 255 TYR A 258 1 O VAL A 256 N VAL A 214 SHEET 1 AA2 7 SER B 85 TYR B 88 0 SHEET 2 AA2 7 HIS B 60 THR B 64 1 N VAL B 61 O SER B 85 SHEET 3 AA2 7 LYS B 36 THR B 40 1 N VAL B 37 O HIS B 60 SHEET 4 AA2 7 MET B 115 LEU B 118 1 O ILE B 117 N ILE B 38 SHEET 5 AA2 7 SER B 164 SER B 170 1 O VAL B 166 N LEU B 116 SHEET 6 AA2 7 SER B 209 LEU B 215 1 O THR B 211 N VAL B 167 SHEET 7 AA2 7 GLU B 255 TYR B 258 1 O VAL B 256 N VAL B 214 SITE 1 AC1 26 GLY A 41 ALA A 42 SER A 43 LYS A 44 SITE 2 AC1 26 GLY A 45 ILE A 46 ALA A 65 ARG A 66 SITE 3 AC1 26 SER A 67 THR A 92 MET A 93 ASN A 119 SITE 4 AC1 26 ILE A 121 VAL A 168 SER A 169 SER A 170 SITE 5 AC1 26 TYR A 183 LYS A 187 LEU A 215 GLY A 216 SITE 6 AC1 26 LEU A 217 ILE A 218 THR A 220 THR A 222 SITE 7 AC1 26 ALA A 223 21T A 302 SITE 1 AC2 11 LEU A 126 SER A 170 LEU A 171 TYR A 183 SITE 2 AC2 11 LEU A 215 GLY A 216 LEU A 217 ALA A 223 SITE 3 AC2 11 NDP A 301 TYR B 280 TYR B 284 SITE 1 AC3 4 GLY A 45 ARG A 48 GLU A 221 LYS A 238 SITE 1 AC4 30 GLY B 41 ALA B 42 SER B 43 LYS B 44 SITE 2 AC4 30 GLY B 45 ILE B 46 ALA B 65 ARG B 66 SITE 3 AC4 30 SER B 67 THR B 92 MET B 93 ASN B 119 SITE 4 AC4 30 HIS B 120 ILE B 121 VAL B 168 SER B 169 SITE 5 AC4 30 SER B 170 TYR B 183 LYS B 187 LEU B 215 SITE 6 AC4 30 GLY B 216 LEU B 217 ILE B 218 THR B 220 SITE 7 AC4 30 THR B 222 ALA B 223 21T B 302 HOH B 402 SITE 8 AC4 30 HOH B 405 HOH B 406 SITE 1 AC5 10 TYR A 280 TYR A 284 SER B 170 LEU B 171 SITE 2 AC5 10 TYR B 177 TYR B 183 LEU B 215 GLY B 216 SITE 3 AC5 10 LEU B 217 NDP B 301 SITE 1 AC6 4 GLY B 45 GLU B 221 LYS B 238 HOH B 406 CRYST1 103.516 103.516 134.780 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009660 0.005577 0.000000 0.00000 SCALE2 0.000000 0.011155 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007419 0.00000